We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+2.91%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$136B
AUM Growth
-$2.12B
(-1.5%)
Cap. Flow
-$3.27B
Cap. Flow
% of AUM
-2.4%
Top 10 Holdings %
Top 10 Hldgs %
35.8%
Holding
339
New
7
Increased
68
Reduced
204
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$156M |
| 2 |
AMTM
Amentum Holdings
AMTM
|
+$150M |
| 3 |
PayPal
PYPL
|
+$71.5M |
| 4 |
New Fortress Energy
NFE
|
+$54.1M |
| 5 |
e.l.f. Beauty
ELF
|
+$50.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.73B |
| 2 |
Wells Fargo
WFC
|
+$293M |
| 3 |
Jacobs Solutions
J
|
+$172M |
| 4 |
KLA
KLAC
|
+$168M |
| 5 |
ExxonMobil
XOM
|
+$165M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.19% |
| 2 | Technology | 30.83% |
| 3 | Industrials | 11.26% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Financials | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Prothena Corp
PRTA
$444M
| $594K | ﹤0.01% |
35,500
-1,000
| -3% | -$21.5K |
|
|
ZIMV
327
DELISTED
ZimVie
ZIMV
| $553K | ﹤0.01% |
34,860
| – | – |
|
|
MURA
328
DELISTED
Mural Oncology
MURA
| $438K | ﹤0.01% |
140,045
-95,506
| -41% | -$311K |
|
329
Nice
NICE
$5.97B
| $391K | ﹤0.01% |
2,250
+250
| +13% | +$42.9K |
|
330
Adaptive Biotechnologies
ADPT
$4.1B
| $389K | ﹤0.01% |
76,030
-70,160
| -48% | -$306K |
|
|
VLRS
331
Controladora Vuela Compania de Aviacion
VLRS
$927M
| $334K | ﹤0.01% |
52,700
| – | – |
|
332
Five Below
FIVE
$13.2B
| $327K | ﹤0.01% |
3,700
-7,200
| -66% | -$606K |
|
333
Bioceres Crop Solutions
BIOX
$21.7M
| $312K | ﹤0.01% |
39,700
| – | – |
|
334
Accuray
ARAY
$36M
| $311K | ﹤0.01% |
172,600
-2,100
| -1% | -$4K |
|
|
MREO
335
Mereo BioPharma
MREO
$45.5M
| $222K | ﹤0.01% |
54,000
| – | – |
|
336
908 Devices
MASS
$371M
| $69.4K | ﹤0.01% |
20,000
-4,830
| -19% | -$21.4K |
|
337
Lowe's Companies
LOW
$123B
| – | – |
-125,000
| Closed | -$27.6M |
|
338
Omnicell
OMCL
$1.7B
| – | – |
-110,769
| Closed | -$3M |
|
339
Veralto
VLTO
$23.7B
| – | – |
-9,667
| Closed | -$923K |
|
Similar funds
VAM
Primecap Management's Q3 2024 Portfolio in Review
As of Q3 2024, Primecap Management held 339 positions worth $136B, down 1.5% from $138B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 2.9%. Primecap Management opened 7 new positions and exited 3, leaving the 339-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.
- Primecap Management's largest Q3 2024 buy was Amentum Holdings: 5,271,282 shares worth $170M.
- Primecap Management added most to ConocoPhillips in Q3 2024, an estimated $156M increase.
- Primecap Management's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $1.73B.
- Primecap Management fully exited Lowe's Companies in Q3 2024, selling an estimated $27.6M.
- Primecap Management's ten largest holdings make up 36% of its $136B portfolio in Q3 2024.
- Primecap Management opened 7 new positions and closed 3 in Q3 2024.
- Primecap Management's portfolio value fell 1.5% quarter-over-quarter to $136B.
Based on Primecap Management's 13F filing for Q3 2024, filed 8 Nov 2024.